Godavari Drugs Ltd - GODAVARI DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE362C01012

Godavari Drugs Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/26/2024 12:00:00 AM

    ₹ 102.22 2.19 2.19
  • Open
  • ₹ 97.55
  • Prev. Close
  • ₹ 100.03
  • Turnover(Lac.)
  • ₹ 19
  • Day's High
  • ₹ 102.98
  • Day's Low
  • ₹ 97.55
  • 52 Week's High
  • ₹ 114
  • 52 Week's Low
  • ₹ 76.21
  • Book Value
  • ₹ 46.591
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 76.97
  • P/E
  • 18.56
  • EPS
  • 5.39
  • Divi. Yield
  • 0

Godavari Drugs Ltd Corporate Actions

06 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2024

12:00 AM

07 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Nov , 2023

12:00 AM

21 Jul , 2023

12:00 AM

AGM

Announcement date: 21 Jul , 2023

View Details

03 Aug , 2023

12:00 AM

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Jul , 2023

12:00 AM

BookCloser

View Details

No Record Found


Godavari Drugs Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Godavari Drugs Ltd SHAREHOLDING SNAPSHOT
26 April , 2024 | 07:59 PM

PROMOTER - TOTAL53.16%

Indian: 53.16%

Foreign: 0%

NON-PROMOTER - TOTAL 46.84%

Institutions: 0.50%

Non-Institutions: 46.34%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Godavari Drugs Ltd FINANCIALS

No Data Available To Display Chart

Godavari Drugs Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Godavari Drugs Ltd

  • Mukund Kakani
  • Managing Director
  • S A Hussain
  • Non-Exec. & Independent Dir.
  • Mohit Jaju
  • Whole Time Director & CFO
  • Ramesh Babu Telugu
  • Non-Exec. & Independent Dir.
  • Vimala B Madon
  • Non-Exec. & Independent Dir.
  • Ghanshyam Jaju
  • Chairman (Non-Executive)
  • Mahindra Uday Bhalerao
  • Non Executive Director
  • Venkatesh Achanta
  • Company Sec. & Compli. Officer

Summary

Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for APIs, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa).The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced Pyrazyamide in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of Pyrazyamide of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug.The Company combine their intrinsic strengths in chemistry with capabilities of process development, right from laboratory scale topilot scale in... Read More


Reports by Godavari Drugs Ltd


Reports by Godavari Drugs Ltd

Company FAQ

No Record Found